Mainstream

Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements

Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements

Post ContentadptRead More

You might also be interested in reading Robinhood Launching New Non-Custodial Web3 Crypto Wallet.

February 12, 2025
In Mainstream